# Neurosterix pulls in $105M for schizophrenia drug, taps Cobenfy vets

> **Newsylist Open Intelligence Dossier** · First detected: 2026-11-12 15:29 UTC · Category: Business · Sources: 6 · Current Velocity: 3.67

## Intelligence Brief
"Neurosterix pulls in $105M for schizophrenia drug, taps Cobenfy vets" developed substantial multi-source reporting across the Business sector, tracked across 5 distinct newsrooms by Newsylist.


Key reporting was led by Dealroom, Business Wire, Startupticker.ch and Fierce Biotech. Coverage velocity and cross-outlet momentum were measured using Newsylist open coverage telemetry.


Synthesized from multi-source international reporting and live coverage telemetry under Newsylist open intelligence methodology.

## Verified Facts & Key Claims
### What drove coverage for Neurosterix pulls in $105M for schizophrenia drug, taps Cobenfy vets?
Coverage spiked when 5 independent newsrooms published 5 verified reports during this coverage cycle.

### How did Newsylist track this trend?
Newsylist monitored article arrival rates, source diversity, and cross-outlet validation in real time.

## Multi-Source Evidence Table
| Source Outlet | Headline | Published (UTC) | Verification URL |
|---|---|---|---|
| BioSpace | Neurosterix nabs $105M, recruits Karuna veterans for schizophrenia push | 2026-11-12 08:39 | [Source Link](https://news.google.com/rss/articles/CBMisAFBVV95cUxOZGZMTlhEakhueWZaQTJGalpzWEg4QmdmLVJNZzc2X1Jrcm9uZ043U0J5Nlh2R3BwaHFqV2VNTlN1T0NoUnZwZ3BTRllicjRuN3dlTWNjZTRkQWdXS0Y1MVBTVHJxcUpTck41ZXJidEtYeEdUV25CNHpJR2NjaU02QVpZQTlLNTYwVTVFNWlKN056WmRxREtXTVp5SFRzbkFnNG9MYlF6Sk5veWFkc0l2aA?oc=5) |
| Dealroom | Neurosterix lands $105M Series B for schizophrenia drug | 2026-11-12 08:39 | [Source Link](https://news.google.com/rss/articles/CBMikgFBVV95cUxOSjltb2pFcTFMU1c4VjdUQnlMR1VRQVZYOE03V0Y5NWM1VW9CdlZIbV8zSl9pWHlaWEE2Z2hsRUotcDQyQWEzWlpBcEFyWERwSGxURlZrUzhiTmEwRUd4UUtxcF8wZk1oc0ctNFJQSDg1OUVhS3dkZ0RvLTZCNkE3Q1lubVZFY0g3UlVvYlRSZHc2UQ?oc=5) |
| Business Wire | Neurosterix Announces $105 Million Series B Financing and Appointments of Leading Neuropsychiatry Drug Development Executives | 2026-11-12 08:39 | [Source Link](https://news.google.com/rss/articles/CBMikgJBVV95cUxPckpROThQS3V4akI4RWpsbTY4OUdOQ3NhR0V4b1o2YXJud1VPbGZCQXJZb0xqNjZxVTdEVVVQUGR5azA3ZXBfaTRNNEc4YWRDX0lCVmhRTEhwY2JTYzFRMVMzZk9PR1E2V3lBa2owR2ZOczVtWDhGZXBlZzFGOTRTWjhrbEwyVWdYR0MxVjFLS1p2RllIRE9JQ3R4eWdsME1CSkx5LUtPb1h2MmFpS3JpclNwTmp6TTNCOGc2bWhhcjN1MXBrWTlsN0Z0MFFDdThfZnhMMXNNSEJJNFJ1ejVsSms0Y1JKT1RrMkpnc1lZUTBRM0dyZmphNUlJSnFXNzhhNmV1NENQNTA0dUhmVkRTb1Vn?oc=5) |
| Startupticker.ch | $105 Million to transform neuropsychiatric care by fine-tuning brain signaling | 2026-11-12 08:39 | [Source Link](https://news.google.com/rss/articles/CBMitAFBVV95cUxOSWJkWjVMMDdNVFA0LXVtNmR5NzZDanVMSUZTYTAzc1lTZ3FuTWI2MGY1MlN1cnRBRWxBUWJWbmhvc20xWDd1LXJaREk4aDRVcm1xeDZXNXhERU5tVW5HYnpncGZ4SUdDUUV0VjdrTTBsUnJrY0FiT1FEeFNvR29oV0RlNk9RMTVWcGRiSFNnalZHQVp5OV8wNVZxX0haSThNcDRWYk9FTTNPc00xV1RqRFJadjI?oc=5) |
| Fierce Biotech | Addex spinout Neurosterix raises $105M series B to fund phase 2 schizophrenia trial | 2026-11-12 08:39 | [Source Link](https://news.google.com/rss/articles/CBMiuAFBVV95cUxNb3lEUDJsbXR4VGsyNE1mZlpsWmlrX3FyWUdQbkJMN3ZQN3ZkVnJmc293b0lqNjdaOUJzMEpEQklGWXlDdW9ieEdoWEJoY244TTI2VWFpSWNXZ2tBS2N4WUxJVXRpdlF6c2wyUnA5LVlXNGNpU2FDRW9nbnNhcG1TZWRtSDZZQXRFbzgtRElWZlZFcVhaaFR0T0JvTE1BYzNKdTNmNXh0cWVZa3hfOGpXVUp0ek1mekQ2?oc=5) |
| Endpoints News | Neurosterix pulls in $105M for schizophrenia drug, taps Cobenfy vets | 2026-11-12 08:39 | [Source Link](https://news.google.com/rss/articles/CBMimgFBVV95cUxNc3BOODBfTlZsNkxBdlhEcHdnb1AtNkNZemVGQVJkcnRTa0laX3JJc3V5eW1oeElsNGRpeE9vZ0pQMHRCV285TmRVem8yTmtiTWpLRUs4VVBka09TeGtfQkk3Y1M3ZkREVENqODlMbGdvY2FPUjNXcW5iUm1BTjZOWDRTa2dZOGZaX01lbFJpdGtqa1cwdWZsQkJn?oc=5) |

---
*Canonical Source: https://www.newsylist.com/trend/2026-11-12/neurosterix-pulls-in-105m-for-schizophrenia-drug-taps-cobenfy-vets*
*Synthesized by Newsylist Open Intelligence Engine under E-E-A-T journalistic standards.*